72. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), p. Joint Meeting mit der Polnischen Gesellschaft für Neurochirurgie, 2021
DOI: 10.3205/21dgnc500
Objective: PD dementia (PDD) patients are excluded from the highly effective treatment of STN-DBS since dementia is an accepted contraindication. The DEMPARK study is an ongoing phase-1b trial at our institution with an exploratory endpoint on cognition by combined STN and Nucleus basalis of Meynert[for full text, please go to the a.m. URL]